ArticleMaterials today. Bio2026
A photocuring double-network hydrogel enhances mechanotransduction and scavenges ROS to accelerate pressure injury healing.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic pressure injuries represent a significant clinical challenge, characterized by impaired mechanotransduction and excessive oxidative stress. To address these issues, we developed a double-network hydrogel composed of poly (acrylic acid-co-hydroxyethyl methacrylate-co-N-hydroxysuccinimide ester) (PAHN) and methacrylated silk fibroin (SilMA). This hydrogel featured a unique glucose-responsive secondary polymerization following initial photocuring, enabling autonomous matrix reinforcement in the hyperglycemic wound environment. The material demonstrated a 45-fold increase in storage modulus under high-glucose conditions, providing adaptive mechanical support. Incorporated cyanidin chloride (CC) conferred potent reactive oxygen species (ROS) scavenging capacity. In a hyperglycemic pressure injury model, the hydrogel significantly accelerated wound closure and enhanced neovascularization. Mechanistic studies revealed that these therapeutic benefits were mediated through synergistic activation of the TRPV4-CaMKII mechanotransduction axis and effective mitigation of oxidative stress. This work presented a promising strategy for treating complex chronic wounds by integrating dynamic mechanical reinforcement with targeted biochemical regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.